Macquarie Group LTD Neogenomics Inc Call Options Transaction History
Macquarie Group LTD
- $85.1 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NEO
# of Institutions
276Shares Held
127MCall Options Held
581KPut Options Held
115K-
Black Rock Inc. New York, NY19.7MShares$310 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$223 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$138 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$106 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$104 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.98B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...